Moradi Amir, Bhatia Ashish C, Behr Kathleen, Napekoski Karl, Foldvari Marianna
Moradi MD, Vista California, Vista, California.
Oak Dermatology, Naperville, Illinois.
Dermatol Surg. 2025 Apr 1;51(4):403-408. doi: 10.1097/DSS.0000000000004504. Epub 2024 Dec 5.
Effective topical delivery of large/charged molecules into skin has always been challenging. Chemical penetration enhancers, organic substances that increase permeability of skin, have been in use for decades with variable success. One application of enhancers involves multilamellar vesicles composed of submicron emulsion droplets and micelles surrounded by concentric phospholipid bilayers.
This report introduces the next generation of multilamellar vesicles, termed Tiered-Release Vesicles (TRVs), as a new platform for topical delivery of macromolecules such as peptides and hyaluronic acid (HA).
Fluorescently labeled peptides and HA, diffusion cells, and confocal microscopy were employed to assess the penetration efficiency of macromolecules in TRV formulations using an ex vivo human skin model. Two in vivo studies utilized punch biopsies followed by histochemical staining and analysis.
Based on fluorescent intensity, TRV formulations delivered a large peptide more completely (2-5 fold) into ex vivo human skin than optimized liposomes. The penetration of 2 HA species in TRV formulations was 3- to 13-fold higher than with a simple gel vehicle. In the case studies, reduction of solar elastosis was observed from a topical TRV formulation.
Topical delivery of large peptides and HA into human skin using TRV technology has been demonstrated.
将大分子/带电分子有效经皮递送一直具有挑战性。化学渗透促进剂,即能增加皮肤通透性的有机物质,已使用数十年,效果不一。促进剂的一种应用涉及由亚微米乳液滴和被同心磷脂双层包围的胶束组成的多层囊泡。
本报告介绍了新一代多层囊泡,即分级释放囊泡(TRV),作为一种用于局部递送肽和透明质酸(HA)等大分子的新平台。
使用荧光标记的肽和HA、扩散池以及共聚焦显微镜,采用离体人皮肤模型评估大分子在TRV制剂中的渗透效率。两项体内研究采用打孔活检,随后进行组织化学染色和分析。
基于荧光强度,TRV制剂将一种大肽更完全地(2至5倍)递送至离体人皮肤中,优于优化的脂质体。两种HA在TRV制剂中的渗透率比简单凝胶载体高3至13倍。在案例研究中,观察到局部TRV制剂可减轻日光性弹性组织变性。
已证明使用TRV技术可将大肽和HA局部递送至人皮肤。